Relay Medical Corp (CHX):企業の財務・戦略的SWOT分析

◆英語タイトル:Relay Medical Corp (CHX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE7118FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Relay Medical Corp(Relay), formerly Chromedx Corp, is a medical technology company that develops medical devices for in vitro diagnostics and point-of-care testing. The company offers technologies based on granted and pending patents such as HemoPalm and AUF. Its HemoPalm provides a combination of full CO-oximetry and blood gases in handheld analyzers. Relay also integrates blood gases, electrolytes and CO-oximetry in hand-held analyzers. The company’s AUF develops novel methods of rapid sample preparation for measurement of free therapeutic drugs and hormones, using the existing immunoassays. Its devices are used to treat kidney diseases and diabetic diseases. Relay is headquartered in Toronto, Ontario, Canada.

Relay Medical Corp Key Recent Developments

Mar 25,2021: Relay Medical & Fio commence COVID-19 Rapid Testing for U.S. departing passengers at Toronto pearson airport
Mar 25,2021: Relay appoints strategic advisors to support initiatives in the CARICOM region and cruise industry
Feb 08,2021: Relay Medical provides update on operations and corporate activity
Jan 20,2021: Relay Medical and Fio announce launch of high-throughput COVID-19 ‘Mobile Testing Toolkit’ capable of processing 100 tests per hour
Jan 14,2021: Relay Medical and Glow LifeTech report on successful phase II clinical results for COVID-19 treatment candidate based on its MyCell technology

This comprehensive SWOT profile of Relay Medical Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relay Medical Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Relay Medical Corp – Key Information
Relay Medical Corp – Overview
Relay Medical Corp – Key Employees
Relay Medical Corp – Key Employee Biographies
Relay Medical Corp – Key Operational Heads
Relay Medical Corp – Major Products and Services
Relay Medical Corp – History
Relay Medical Corp – Company Statement
Relay Medical Corp – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Relay Medical Corp – Business Description
Relay Medical Corp – Corporate Strategy
Relay Medical Corp – SWOT Analysis
SWOT Analysis – Overview
Relay Medical Corp – Strengths
Relay Medical Corp – Weaknesses
Relay Medical Corp – Opportunities
Relay Medical Corp – Threats
Relay Medical Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Relay Medical Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Relay Medical Corp, Key Information
Relay Medical Corp, Key Ratios
Relay Medical Corp, Share Data
Relay Medical Corp, Major Products and Services
Relay Medical Corp, History
Relay Medical Corp, Key Employees
Relay Medical Corp, Key Employee Biographies
Relay Medical Corp, Key Operational Heads
Relay Medical Corp, Other Locations
Relay Medical Corp, Subsidiaries

Relay Medical Corp, Key Competitors
Relay Medical Corp, SWOT Analysis
Relay Medical Corp, Ratios based on current share price
Relay Medical Corp, Annual Ratios
Relay Medical Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Relay Medical Corp (CHX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of co …
  • Origin Energy Ltd (ORG):石油・ガス:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Occidental Petroleum Corporation (OXY)-エネルギー分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • Greensmith Energy Management Systems LLC-エネルギー分野:企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …
  • Medica Corp:企業の製品パイプライン分析2018
    Summary Medica Corp (Medica) is a medical device company that manufactures and markets in-vitro diagnostic blood testing analyzers. The company’s products comprise clinical chemistry analyzers, electrolyte analyzers, blood gas analyzers, and hematology analyzers, and OEM ISE modules. Medica’s produc …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • GI Dynamics Inc (GID)-製薬・医療分野:企業M&A・提携分析
    Summary GI Dynamics Inc (GI Dynamics) is a medical device company that develops and commercializes endoscopy instruments. The company’s product includes EndoBarrier, an endoscopically delivered device therapy that is designed to mimic the mechanisms of metabolic surgery- without altering the anatomy …
  • LafargeHolcim Ltd. :企業の戦略・SWOT・財務情報
    LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report Summary LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Divi’s Laboratories Ltd (DIVISLAB):企業の財務・戦略的SWOT分析
    Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Public Power Corporation SA (PPC)-エネルギー分野:企業M&A・提携分析
    Summary Public Power Corporation S.A. (PPC) is power producer and electricity supply company. The company designs, constructs, maintains and operates power plants. It also generates, transmits and distributes electricity. The company generates power from lignite, fuel oil, and natural gas based plan …
  • Heijmans NV:企業の戦略・SWOT・財務情報
    Heijmans NV - Strategy, SWOT and Corporate Finance Report Summary Heijmans NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • National Cancer Centre Singapore-製薬・医療分野:企業M&A・提携分析
    Summary National Cancer Centre Singapore (NCCS) is a healthcare service provider that offers research and cancer treatment services. The center offers research for cancers such as breast, gynaecology, haematology, head and neck, neuro oncology, naso pharynx cancer, paediatrics, reconstructive, hepat …
  • Ray Sigorta A.S.:企業の戦略・SWOT・財務情報
    Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report Summary Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Breckenridge Pharmaceutical Inc:企業のM&A・事業提携・投資動向
    Breckenridge Pharmaceutical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Breckenridge Pharmaceutical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Cerner Corp (CERN):企業の財務・戦略的SWOT分析
    Cerner Corp (CERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Golden Meditech Holdings Ltd (801):企業の財務・戦略的SWOT分析
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Dynacq Healthcare Inc (DYII):企業の財務・戦略的SWOT分析
    Summary Dynacq Healthcare Inc (DHI) is a healthcare consulting organization that provides surgical services. The organization develops and manages general acute hospitals that provide general surgeries. Its hospitals are designed to handle operations such as orthopaedics, neurosurgery and general su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆